World Journal of Nuclear Medicine

LETTER TO EDITOR
Year
: 2020  |  Volume : 19  |  Issue : 2  |  Page : 179-

Clinical significance of thyroid incidentalomas detected on fluorodeoxyglucose positron emission tomography scan (PETomas): Its original description and now


Jacques How1, Roger Tabah2, Elliot J Mitmaker2,  
1 Division of Endocrinology, McGill University Health Center, Montreal, Quebec, Canada
2 Department of Surgery, McGill University Health Center, Montreal, Quebec, Canada

Correspondence Address:
Dr. Elliot J Mitmaker
Department of Surgery, Section of Endocrine Surgery, McGill University Health Centre, Royal Victoria Hospital, Glen Site, 1001 Boul Decarie, Bureau D02.7324,Montréal, Québec H4A 3J1
Canada




How to cite this article:
How J, Tabah R, Mitmaker EJ. Clinical significance of thyroid incidentalomas detected on fluorodeoxyglucose positron emission tomography scan (PETomas): Its original description and now.World J Nucl Med 2020;19:179-179


How to cite this URL:
How J, Tabah R, Mitmaker EJ. Clinical significance of thyroid incidentalomas detected on fluorodeoxyglucose positron emission tomography scan (PETomas): Its original description and now. World J Nucl Med [serial online] 2020 [cited 2020 Aug 4 ];19:179-179
Available from: http://www.wjnm.org/text.asp?2020/19/2/179/286461


Full Text



Dear Editor,

We read with much interest the paper,[1] “Clinical significance of thyroid incidentalomas detected on fluorodeoxyglucose positron emission tomography scan (PETomas): An Indian experience” by Kumar et al. published in the July–September 2019 issue of your journal. In April 2011, our team published our findings on this topic, at which time we suggested that this thyroid entity should be called “PETomas.”[2] We are, therefore, extremely surprised that Kumar et al. did not cite our publication and acknowledge our role in initiating the use of the term “PETomas.”

We would also like to draw the attention of your readers to a paper published in 2008 by Katz and Shaha of the Memorial Sloan-Kettering Cancer Center, wherein they proposed that this thyroid finding should be called “PET-associated incidental neoplasms (PAINS).”[3] Neither “PAINS” nor “PETomas” have thus far caught on in the literature so that we heartily welcome the usage of “PETomas” by Kumar et al. We believe that this term is simple and meaningful.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

References

1Kumar AA, Datta G, Singh H, Mukherjee PB, Vangal S. Clinical significance of thyroid incidentalomas detected on fluorodeoxyglucose positron emission tomography scan (PETomas): An Indian experience. World J Nucl Med 2019;18:273-82.
2Nishimori H, Tabah R, Hickeson M, How J. Incidental thyroid “PETomas”: Clinical significance and novel description of the self-resolving variant of focal FDG-PET thyroid uptake. Can J Surg 2011;54:83-8.
3Katz SC, Shaha A. PET-associated incidental neoplasms of the thyroid. J Am Coll Surg 2008;207:259-64.